For the final installment in Vynamic’s 2025 health industry outlook series, Jen is joined by Vynamic’s Head of Life Sciences, Karen Baldry, and Head of Life Sciences Europe, Gemma Pfister, to focus on the Life Sciences industry – the trends most impacting the pharmaceutical and biotech sectors.To learn more about Vynamic’s overall 2025 Health Industry Outlook, visit: <a href="https://vynamic.com/insights/navigating-turbulence-and-transformation-2025-health-industry-outlook/" style="background-color:rgb(255,255,255);color:rgb(5,99,193);">https://vynamic.com/insights/navigating-turbulence-and-transformation-2025-health-industry-outlook/</a>Podcast Tags: healthcare, healthcare news, life sciences, pharmaceutical, biotech, Inflation Reduction Act, product launch, direct-to-consumer, pharmacy, integrated delivery networksPanel – Karen Baldry, Gemma Pfister, Jen BurkeResearch &amp; Production – Jen Burke, Mindy McGrathRecording &amp; Editing – Mike Liberto, Rachel SkoneckiFor additional discussion, please contact us at <a href="%5C">TrendingHealth.com</a>.